HOSPITAL UNIVERSITARIO INFANTA SOFÍA
Departamento
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (35)
2024
-
Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP
Clinical and Translational Oncology
2023
-
Incidence and management of patients with methotrexate delayed elimination in the clinical practice: A Delphi study
Journal of Oncology Pharmacy Practice, Vol. 29, Núm. 4, pp. 794-801
-
One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients
Blood Cancer Journal, Vol. 13, Núm. 1
2022
-
Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients
Annals of Hematology, Vol. 101, Núm. 9, pp. 2053-2067
-
Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience
Cancers, Vol. 14, Núm. 7
2021
-
Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group
Leukemia and Lymphoma, Vol. 62, Núm. 12, pp. 2928-2938
-
Clinical characterization and outcomes of 85 patients with neurosarcoidosis
Scientific Reports, Vol. 11, Núm. 1
-
Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients
Joint Bone Spine, Vol. 88, Núm. 6
-
Outcomes of surgical resection after neoadjuvant chemoimmunotherapy in locally advanced stage IIIA non-small-cell lung cancer
European Journal of Cardio-thoracic Surgery, Vol. 60, Núm. 1, pp. 81-88
-
Seghi study: Defining the best surveillance strategy in hodgkin lymphoma after first-line treatment
Cancers, Vol. 13, Núm. 10
2020
-
Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).
Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 4, pp. 657-662
-
Hormonal Dependence and Cancer in Systemic Lupus Erythematosus
Arthritis Care and Research, Vol. 72, Núm. 2, pp. 216-224
-
Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross-Sectional Study
Arthritis Care and Research, Vol. 72, Núm. 6, pp. 822-828
2019
-
Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR study
Rheumatology International, Vol. 39, Núm. 12, pp. 2015-2024
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
-
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364
-
Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology
Reumatologia Clinica, Vol. 15, Núm. 5, pp. 252-257
-
Systemic phenotype of sarcoidosis associated with radiological stages. Analysis of 1230 patients
European Journal of Internal Medicine, Vol. 69, pp. 77-85
2018
-
Biologic Disease-modifying antirheumatic drug attributes in the first lines of treatment of rheumatoid arthritis. 2015 ACORDAR project
Reumatologia Clinica, Vol. 14, Núm. 2, pp. 90-96
-
Recommendations for the use of parenteral methotrexate in rheumatic diseases
Reumatologia Clinica, Vol. 14, Núm. 3, pp. 142-149